Immunohistochemistry results indicated that high expression of KPNA2 expressed significant association with a poor tumor grade, an advanced FIGO stage, recurrence and uncontrolled, resistance/refraction to initial chemotherapy, and SALL4 level in these patients. The gene discussed is SALL4; the disease is neoplasm.